Aim: Controlled ovarian hyperstimulation results in elevated levels of estrogen during in vitro fertilization (IVF). Although serum ovarian steroid hormones were found to influence central nervous system and anesthetic requirements, the relationship between propofol requirements and serum estrogen concentration in women undergoing oocyte retrieval has not been studied. The aim of this study was to determine the relationship between serum estrogen and progesterone concentrations and the required propofol dose for loss of consciousness (LOC). Methods: Ninety patients undergoing oocyte retrieval for IVF were enrolled. Anesthesia was induced by administration of 200 mL/h propofol (1%) infusion to reach LOC. Anesthesia was maintained with a propofol infusion guided by entropy. The correlation between estrogen, progesterone levels and propofol dose at the time of LOC was analyzed. Emergence time from anesthesia and total propofol consumption were recorded. Results: The mean serum estradiol concentration was 1825 AE1135 pg/mL. There was a significant positive correlation between serum estradiol and propofol dose required for LOC (Pearson's correlation r = 0.28, P = 0.008). Progesterone had no significant correlation with total propofol dose at the time of LOC. Patients with high estradiol levels (higher than the median value) had similar propofol requirement for LOC, total propofol consumption and emergence time with patients who had low (below the median value) levels. Conclusion: Although increased estrogen levels create a positive correlation with propofol dose for LOC, estrogen does not seem to be the only factor for anesthetic requirement of patients undergoing controlled ovarian hyperstimulation.
Introduction
Supraphysiologic levels of estradiol (E2) are attained during controlled ovarian hyper stimulation owing to the development of multiple ovarian follicles. Despite this accelerating rise in estrogen levels, no such changes in serum progesterone concentrations have been observed following the use of gonadotrophinreleasing hormone agonists. 1, 2 Besides in vitro fertilization (IVF) outcomes, estrogen and progesterone, which are steroid-structured substances, have been proven to have effects on the central nervous system. 3 Several previous studies have shown that female sex hormones, especially progesterone and its metabolites, facilitate gamma-aminobutyric acid (GABA)-ergic neurotransmission through direct action on the GABA type A receptor, 4, 5 resulting in sedation, anxiolysis and analgesia; and estrogen is thought to suppress GABA A receptor-mediated inhibition. 6 Glutamatergic neurotransmission is also proposed to be affected by sex steroids; progesterone has been shown to suppress the glutamate-related excitatory response in a dose-dependent manner, 7 whereas estrogen magnifies glutamate transmission. 8 Hence, the interaction between excitation and inhibition modulated by female sex steroids could have an influence on anesthetic and analgesic requirements of normal menstruating woman. The effect of high estrogen levels on anesthetic requirement during oocyte retrieval procedures warrants investigation because low fertilization rates have been observed after longer or high-dose exposure to anesthetic agents. 9, 10 Therefore, we performed this prospective, observational study to test the hypothesis that serum concentrations of estrogen affect propofol requirements of woman undergoing oocyte retrieval.
Methods
The study was performed in the IVF unit of a woman's tertiary teaching hospital between May 2017 and September 2017. All study documents and procedures were approved by the institutional review board and the ethics guidelines of the Helsinki Declaration were applied. Written informed consent was obtained from 100 woman aged 18-45 years with American Society of Anesthesiologists physical status class I or II, who were scheduled to undergo transvaginal oocyte retrieval for IVF. The exclusion criteria included acute or chronic use of psychotropic drugs; hepatic, renal, neurologic dysfunction; alcoholism; and use of benzodiazepines, opioids or anticonvulsants. In addition, patients with a body mass index (BMI) >40 or <18 kg/m 2 were excluded. Patients received no anesthetic premedication. On arrival in the operating room, a 20-gauge intravenous (IV) catheter line was inserted for administration of 5 mL/kg/h 0.9% sodium chloride solution. Standard monitoring measures were applied to the patients, including noninvasive blood pressure (NIBP), fivelead electrocardiogram for heart rate (HR), pulse oximetry (SpO 2 ) and an entropy module (GE DatexOhmeda S5 Avance workstation, GE Healthcare, Finland). The entropy module measures depth of anesthesia by data acquisition of electroencephalograph (EEG) and frontal electromyography (EMG) signals. The device derives these spectral entropies as response entropy (RE) and state entropy (SE) by the entropy sensor electrode placed on the patient's forehead after cleaning of the skin with alcohol, as described by the manufacturer. RE (display range 0-100) is sensitive to activation of facial muscles (i.e. frontal EMG) and gives early indications of emergence within less than 2 s as a quick rise. SE (display range 0-91) estimates the hypnotic effects of anesthetic drugs on the brain and consists of EEG signals. The recommended threshold value for adequate general anesthesia is between 40 and 60 for both RE and SE.
Anesthesia was induced with a continuous 1% propofol infusion at 200 mL/h until loss of consciousness (LOC). LOC was defined as loss of verbal stimulus, which was tested by asking the patient to say their name with a normal voice without tactile stimulus every 15 s. After LOC was achieved, all patients received 1.5 μg/kg fentanyl injections. Anesthesia was maintained with continuous infusion of 1% propofol at 100 μg/kg/min along with 50% O 2 to maintain the SE value between 40 and 60. If the SE value was >60, a 0.5 mg/kg propofol bolus was given, followed by a stepwise rise of infusion with 20 μg/kg/ min incremental doses up to a 200 μg/kg/min maximum dose. On the other hand, if the SE value was <40, the propofol infusion rate was stepped-down by 20 μg/kg/min. If the RE-SE difference was greater than 10, fentanyl 0.5 μg/kg IV was given. During the procedure, patients breathed spontaneously 50% oxygen with a face mask.
The infusion of propofol was stopped after removal of the transvaginal probe. After the propofol infusion was stopped, using a normal voice and without tactile stimulation, patients were asked to open their eyes every 15 s to detect emergence from anesthesia. Duration of the anesthesia was defined as the time elapsed between LOC and eyes opening after cessation of propofol. 11 Emergence time from anesthesia was defined as the time elapsed between discontinuation of propofol and spontaneous eye opening. 12 Venous blood samples were collected from all patients before the oocyte retrieval procedure. Blood estrogen and progesterone measurements were performed using chemiluminescence immunoassays with an automated Elecsys immunoanalyzer (ECLIA, Roche diagnostics, Meylan, France). The assay sensitivity was 5 pg/mL for E 2 and 0.03 ng/mL for progesterone. The intra and inter-assay coefficients of variation were 5% and 10% for E 2 , and 3% and 5% for progesterone, respectively.
The values of NIBP, HR, SpO 2 , SE and RE were recorded every 2 min from the beginning of induction and emergence from anesthesia. The total propofol and fentanyl dose were recorded at the time of LOC and the emergence from anesthesia. The total number of follicles noted by ultrasound prior to retrieval was recorded.
Statistical analysis
In this study, the primary outcome was the relationship between E 2 and propofol consumption. We assumed that the correlation coefficient between E 2 and total propofol consumption was 0.3. The sample size calculation determined that 85 patients would be required to differentiate between correlation coefficient 0.3 and 0 with a significance level of 0.05 (α = 0.05) and power of 80% (β = 0.20); to allow for attrition, the sample size was increased to 100.
The normality of serum, concentrations of progesterone, E 2 and propofol, fentanyl consumptions was tested using the Shapiro-Wilk test. For further analysis, patients were divided into two groups based on the E 2 concentration -a similar comparison of patients was used by Lee et al. based on progesterone concentration 13 ; a group with E 2 values greater than the median value (high group) and a group with E 2 values lower than median value (low group). Continuous variables were compared using Student's t-test and the Mann-Whitney U-test when the data not normally distributed. Correlations between variables were tested using Pearson's correlation coefficients. Partial correlation coefficients were calculated while controlling for anesthesia time and patient weight on the relationship between propofol dose and others. A P-value <0.05 was considered to be significant. Statistical analyses were performed using the IBM SPSS version 23.0 statistical software.
Results
One hundred patients were enrolled in the study; 10 patients were excluded. Three had problems with the entropy module and seven had unrecognized exclusion criteria. The patients' characteristics are presented in Table 1 . The mean serum E 2 and progesterone concentrations were 1825.6 AE 1135.9 pg/mL and 3.8 AE 4.1 ng/mL, respectively. Propofol consumption at the time of LOC (values were controlled for patient weight and duration of anesthesia) had a positive correlation with serum E 2 concentration (Pearson's correlation r = 0.28, P = 0.008) (Fig. 1) ; there was no significant correlation with progesterone (P = 0.061).
The total propofol requirement at the time of emergence (values were controlled for patient weight and duration of anesthesia) had a positive correlation with serum E 2 concentrations (Pearson correlation r = 0.26, P = 0.013) (Fig. 2) ; there was no significant correlation with progesterone (P = 0.24).
There was significant positive correlation between the number of follicles and propofol consumption (values were controlled for patient weight and duration of anesthesia) at the time of LOC (Pearson correlation r = 0.220, P = 0.04); no correlation was observed at the time of emergence (Pearson correlation r = 0.192, P = 0.07).
The median serum concentration of E 2 was 1477 pg/mL. Forty-five patients comprised the high group (serum E 2 concentration above the median value), and 45 patients constituted the low group (serum E 2 concentration below the median value).The two groups were similar in terms of age, weight, height, BMI and duration of anesthesia ( Table 2 ). The median serum concentration of progesterone was 3.48 (range, 0.84-27.24) ng/mL in the high group versus 2.0 (range, 0.28-26.6) ng/mL in the low group (P < 0.001).
The required propofol dose for LOC was 140 (range, 100-200) mg in the high group and 130 (range, 50-170) mg in the low group (P = 0.07) ( Table 2 ).
The total propofol consumption at the time of emergence was 220 (range, 130-400) mg in the high group and 190 (range, 75-370) mg in the low group (P = 0.07).
The fentanyl requirements were comparable between the high group (97.5 [range, 75-158] μg) and the low group (97.5 [range, 60-127.5] μg) (P = 0.81).
Emergence time was also comparable between the high group at 4 min (range, 1-7) and the low group 4 min (range, 2-10) (P = 0.32).
When plasma E 2 and progesterone concentrations were controlled for propofol consumption, there were no significant correlation between average RE, SE and emergence times, and plasma E 2 and progesterone concentrations (Table 3) .
Discussion
In the present study, we have demonstrated that the required propofol dose for LOC and total propofol consumption at the time of emergence in patients undergoing oocyte retrieval were directly correlated with E 2 levels, but had no correlation with progesterone levels. On the other hand, anesthetic, analgesic requirements and the time of emergence from anesthesia were not different between ovarian-stimulated patients with high or low levels of E 2 concentrations.
Most clinical studies with similar results have examined anesthetic requirements of woman during pregnancy, cesarean section, after delivery and at different phases of the menstrual cycle. In some of these studies, inhalational anesthetic agents were used, and the alveolar concentration of anesthetic gases needed to cause immobilization in 50% of subjects during painful surgical stimuli was defined as the minimum alveolar concentration (MAC). The average value for MAC over the course of an hour for sevoflurane was found significantly higher in patients in the follicular phase than in patients in the luteal phase.
14 In pregnant women undergoing cesarean delivery, sevoflurane consumption was inversely correlated with the serum progesterone concentration. 13 Similarly, the MAC of isoflurane was decreased during early pregnancy when the progesterone concentration was higher than in nonpregnant patients. 15 In a study in which propofol was chosen as an IV anesthetic agent for the comparison of anesthetic requirement between the luteal and follicular phases of the menstrual cycle, there was a reduction in propofol requirement for LOC and the whole procedure. 12 In these studies, progesterone was found as the primary effective ovarian hormone that determined the anesthetic requirement for female patients.
Owing to the difference in the mechanism of action of estrogen and progesterone, we were interested in patients treated with gonadotropins to create an environment for follicular development where high levels of estrogen compare to progesterone are acquired. In the current study, we observed that propofol doses for LOC and the entire procedure were directly correlated with estrogen levels, but had no correlation with progesterone. Our results may initially seem counterintuitive compared with other studies in which progesterone was accepted as the primary hormone that affected anesthetic consumption. One possible explanation for this phenomenon is that the mean E 2 level was relatively higher compared with the mean Values are mean AESD, numbers (%) or median (25th-75th) percentile. P < 0.05 bold values are represent statistically significant. The median value of serum E 2 concentration was 1477 pg/mL. Low and high groups include women with E 2 concentrations above and below the median value, respectively. BMI, body mass index; E 2, Estradiol; LOC, loss of consciousness progesterone level in our patients. With this level of E 2 , the progesterone effect on anesthetic consumption could be alleviated. We also found no difference between the patients with high and low levels of E 2 in terms of propofol dose for LOC and total propofol dose. This finding supports our hypothesis because patients with high estrogen levels also had high progesterone compared with patients with low estrogen. Therefore, these counteractive hormones might prevent the significant difference in propofol doses. Two studies found an inverse correlation with plasma estrogen and anesthetic requirement. 16, 17 Yavuz et al. reported decreased anesthetic consumption with higher levels of estrogen in women undergoing gynecologic surgery. The results of the present study are in contrast with Yavuz et al.'s results; however, there are few differences between the two studies, which may account for these contradictory results. First, the mean estrogen concentration was lower in Yavuz et al.'s study. Second, small patient numbers were included in their three groups that were created according to estrogen levels, which might not reflect appropriate sample-sized study results. In another study, it was suggested that high estrogen levels were correlated with decreased resistance to barbiturates during early pregnancy. Although the patients in the early pregnant group had higher estrogen concentrations compared with the premenopausal and postmenopausal groups, the differences in estrogen concentrations between the three groups were much smaller than the range in our current study. This small difference may explain the different results gained from our study.
The mechanism for different anesthetic requirements in patients with follicular and luteal menstrual phases is explained by the progesterone-related central effect via direct action on the GABA A receptor complex. It has been suggested that the potency of its action on GABA-mediated synaptic inhibition is as great as with benzodiazepines, whose effects on anesthesia are well documented. 18, 19 Unlike progesterone, estrogen augments neuronal excitability through its interaction with the GABA receptor. 20 In the present study, we analyzed the correlation between the required propofol dose at LOC and female sex hormones and showed that only estrogen levels had a significant positive correlation. This suggests that the increased propofol requirement for LOC and total retrieval procedure may result from high estrogen concentration in patients undergoing oocyte retrieval. Despite this positive correlation, we found no decreased anesthetic requirement between patients with high and low estrogen levels. Such a finding suggests that estrogen is not the only factor that influences anesthetic depth in patients undergoing oocyte retrieval, as defined using entropy monitor components.
The aim of controlled ovarian stimulation is to recruit a greater number of developed follicles for harvesting suitable oocyte numbers during IVF. Supraphysiologic levels of E 2 are attained during IVF treatment cycles because each ovarian follicle contributes to E 2 production. Elevated levels of estrogen have been associated with increases in cardiac output accompanied by a reduction in total peripheral resistance during ovulation induction. 21 Similarly, the cardiac output increase seen during ovarian hyperstimulation syndrome was associated with tachycardia and peripheral vasodilatation, which may be the result of high levels of estrogen. 22 An increase in cardiac output reduces the fraction of drug distributed to the brain and increases the rate of redistribution, which results in the higher dose requirement during anesthesia of patients with elevated estrogen levels. The potential pharmacokinetic interaction between increased cardiac output and propofol likely contributes to the higher propofol requirements for LOC in patients undergoing oocyte retrieval.
The bispectral index (BIS) and entropy are commonly used monitors derived from EEG to measure depth of anesthesia. Both monitors use sensors placed on the forehead to obtain optimal measurement results. BIS monitors show only one index to interpret the depth of anesthesia. Although this single index assessment is easy to use for anesthetists, facial EMG contamination could result in incorrect assessment of nociception and arousal, even during hypnosis with propofol. [23] [24] [25] There are two entropy parameters that are reflective of nociceptive and hypnotic level during general anesthesia, as described above in the method section. The difference between the fast-reacting RE and the steadier SE gives an idea about analgesic need, and a difference of more than 10 indicates demand for supplemental analgesia to the patients. 26 In this way, additional opioid use decreases propofol consumption and optimizes the total hypnotic drug delivery to patients. Therefore, our study results reflect the effects of sex steroids on anesthetic consumption with greater accuracy compared with other studies in which depth of anesthesia was monitored using BIS and analgesic requirement was evaluated using hemodynamic parameters or only single-dose opioid used for analgesia.
Our study has a number of limitations. First, the study did not take diurnal variations of progesterone and estrogen concentrations into consideration. However, all oocyte retrieval procedures took place early in the morning. Second, controlled ovarian hyperstimulation includes many hormonal changes including changes in follicle-stimulating hormone, luteinizing hormone and human chorionic gonadotropin, and these substances were not studied.
In summary, the findings in the current study showed that propofol dose for LOC and total propofol consumption of patients undergoing oocyte retrieval were directly correlated with estrogen concentration. In addition, estrogen was shown not to be the only factor that determines the anesthetic requirement of patients undergoing controlled ovarian stimulation. A high progesterone concentration together with a high level of estrogen would probably prevent a significant difference between propofol consumptions of low and high estrogen level groups.
